In vitro analysis of equine, bone marrow-derived mesenchymal stem cells demonstrates differences within age- and gender-matched horses.
Authors: Carter-Arnold J L, Neilsen N L, Amelse L L, Odoi A, Dhar M S
Journal: Equine veterinary journal
Summary
# Editorial Summary Mesenchymal stem cell (MSC) therapies have become standard practice in equine medicine, yet most characterisation studies focus on young horses despite middle-aged animals being the primary candidates for treatment due to their ongoing athletic demands and increased susceptibility to degenerative conditions. Carter-Arnold and colleagues investigated bone marrow-derived MSCs from middle-aged horses using in vitro analysis, examining how cells performed across age- and gender-matched cohorts to determine whether biological variability existed within this seemingly homogeneous population. Their findings demonstrated significant differences in MSC characteristics between individual horses of similar age and sex, suggesting that donor variability—rather than age alone—substantially influences cell behaviour and therapeutic potential. These results carry important implications for practitioners: standardised protocols assuming predictable MSC function may not account for individual biological variation, potentially explaining inconsistent clinical outcomes when using autologous or allogeneic stem cell therapies. Tailoring MSC selection and treatment approaches to individual donor characteristics, rather than relying solely on demographic criteria, may therefore optimise therapeutic efficacy in equine regenerative medicine.
Read the full abstract on PubMed
Practical Takeaways
- •Stem cell therapy outcomes may vary between individual middle-aged horses even when matched for age and sex; consider individual donor characteristics when selecting candidates
- •Age alone is insufficient for predicting stem cell quality—individual variation should factor into clinical decision-making for MSC-based treatments
- •Middle-aged horses undergoing stem cell therapy may have different cell biology than younger horses typically studied, potentially affecting treatment efficacy
Key Findings
- •Mesenchymal stem cells from middle-aged horses show demonstrable differences compared to age- and gender-matched controls in vitro
- •Individual variation in stem cell characteristics exists within horses of similar age and gender
- •Middle-aged athletic horses warrant investigation for stem cell therapy applications despite limited published characterization